Načítá se...
PD-1 expression and clinical PD-1 blockade in B-cell lymphomas
Programmed cell death protein 1 (PD-1) blockade targeting the PD-1 immune checkpoint has demonstrated unprecedented clinical efficacy in the treatment of advanced cancers including hematologic malignancies. This article reviews the landscape of PD-1/programmed death-ligand 1 (PD-L1) expression and c...
Uloženo v:
| Vydáno v: | Blood |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society of Hematology
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5755041/ https://ncbi.nlm.nih.gov/pubmed/29118007 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2017-07-740993 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|